Paracetamol Spirig HC

Quick links

Choose a section

Quick links to important sections

Advertisements

Paracetamol Spirig HC

Advertisements
Advertisements

Overview of Paracetamol Spirig HC

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Tablets, oral solution, or suppositories
Pharmacological Class Analgesic and Antipyretic
Common Use Relief from pain and fever
Origin Synthetic compound

Paracetamol Spirig HC: Definition and Pharmacological Identity

Paracetamol Spirig HC is a proprietary pharmaceutical agent whose active substance is Paracetamol, internationally known as Acetaminophen. This medicine is classified as both an analgesic (pain reliever) and an antipyretic (fever reducer), supported by pharmacological studies recognized by major health authorities. This confirms that the medicine's role in easing discomfort and reducing temperature is clinically recognized.

As a specific brand produced by Spirig HC, its formulations are widely available as an over-the-counter (OTC) product. Unlike Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, Paracetamol's action profile is primarily centralized, distinguishing it pharmacologically from compounds that target inflammation in peripheral tissues.

Composition, Pharmaceutical Form, and Origin

The product contains Paracetamol as its primary active ingredient, confirming its status as a single-ingredient preparation in its standard form. The active substance is a synthetic compound, manufactured through established chemical processes, and is not naturally occurring.

Paracetamol Spirig HC is offered in a variety of pharmaceutical preparations, including various forms of tablets for oral administration, and a liquid oral solution. For specific patient needs, the active ingredient is also formulated into suppositories for rectal administration. The availability of both oral and rectal forms allows flexibility in managing symptoms for individuals who may struggle with swallowing tablets.

General Therapeutic Purpose and Core Benefit

The overarching purpose of the medicine is to provide focused, symptomatic relief through two established physiological actions: Central Pain Modulation and Hypothalamic Thermoregulation. By intervening in the central regulatory systems, it assists the body in normalizing an abnormally elevated core temperature. This dual functionality is highly valued for addressing the general symptoms of pain and fever that accompany minor ailments.

Regulatory References

  1. NCBI Bookshelf Source
Advertisements

What side effects are possible with Paracetamol Spirig HC?

Adverse Reaction Scope and Classification

Adverse reactions associated with paracetamol are generally rare at recommended therapeutic doses. The key organ systems involved in adverse events, particularly serious ones, are the liver (hepatobiliary system), the immune system, and the blood and lymphatic system.

Very Rare Adverse Reactions (<1/10,000):

System-Organ Class Specific Reactions (Very Rare)
Immune System/Skin Anaphylaxis, severe cutaneous hypersensitivity reactions (e.g., Stevens-Johnson syndrome, Toxic Epidermal Necrolysis), skin rashes, angioedema.
Blood and Lymphatic System Thrombocytopenia (a reduction in blood platelets).
Hepatobiliary Disorders Hepatic dysfunction, which can progress to liver failure, especially in overdose.
Respiratory Disorders Bronchospasm, primarily observed in patients who have a known sensitivity to aspirin or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs).

Safety Considerations and Restrictions

Paracetamol is contraindicated in individuals with a known hypersensitivity to the active substance or its excipients. It is also contraindicated in patients with severe hepatic functional disorders, such as active decompensated liver disease, cirrhosis, or hereditary constitutional hyperbilirubinaemia (Gilbert's disease).

Key Safety Restrictions and Warnings:

  • Hepatotoxicity Risk: The primary concern with paracetamol is liver damage (hepatotoxicity), which is most often linked to exceeding the maximum recommended dose. The risk is significantly increased in patients with chronic alcoholism, malnutrition, or glutathione deficiency.
  • Dose Limitation: Official guidance stresses the importance of adhering strictly to the maximum dose and duration. Immediate medical attention is necessary in cases of suspected overdose, even if no symptoms are immediately apparent, due to the risk of delayed but potentially fatal liver damage.
  • Population-Specific Caution: Caution is advised for patients with mild to moderate liver impairment or severe renal impairment. In cases of chronic alcoholism, a reduced maximum daily dose is recommended in regulatory documents.
Advertisements

Overdose and Emergency Response

The official regulatory profile for Paracetamol (Acetaminophen) overdose emphasizes the danger of time-delayed, progressive toxicity. Initial manifestations may be non-specific, including nausea, vomiting, anorexia, malaise, paleness, or sweating. These early signs do not reflect the ultimate severity of the overdose, as serious toxicity may be delayed for days.

The most critical and life-threatening outcome documented in regulatory labeling is severe hepatic injury leading to acute liver failure, with the potential for renal failure and death. Later clinical signs of severe toxicity can include jaundice, confusion, or pain in the upper right abdomen.

Regulatory authorities strictly mandate that immediate medical attention must be sought following any suspected ingestion of an excessive amount of Paracetamol. This action is required even if initial symptoms are mild or absent, due to the need for prompt medical intervention and continuous hospital monitoring.

Treatment protocols are time-sensitive, governed by the measured serum acetaminophen concentration. The official antidote, N-acetylcysteine (NAC), is indicated for use, but its effectiveness is maximized with early administration. Increased risk of severe toxicity is documented for patients with pre-existing hepatic impairment, chronic alcoholism, or severe malnutrition.

Advertisements

Therapeutic Uses of Paracetamol Spirig HC

The fundamental purpose of Paracetamol Spirig HC (Acetaminophen) is to offer symptomatic relief across key therapeutic domains marked by discomfort or fever, helping to ease the overall burden of acute and recurrent manifestations.

This agent is commonly used in conditions involving episodic or fluctuating symptom patterns where it provides supportive symptom management.

Primary Therapeutic Uses and Patient Benefit

This medication is applied across conditions presenting with acute episodes, where it helps address symptom clusters that may become intense or disruptive. It is commonly used to ease the intensity of discomforts such as headaches, toothache, menstrual cramps, muscle aches, and the fever and systemic aches associated with the common cold or flu. This contributes to easing the overall symptom load and may assist with maintaining functional stability when symptoms are more noticeable.

In clinical settings that involve acute or unstable symptom patterns, the medication is relevant for easing symptoms related to physical discomfort and systemic imbalance. This is relevant in contexts involving heightened systemic burden or after minor procedures, where additional management of discomfort is required.


Quick Fact: Relief for Systemic and Localized Discomfort

Paracetamol is used for managing symptoms related to systemic imbalance and symptoms related to physical discomfort.

Regulatory References

  1. NIH MedlinePlus Overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Paracetamol Spirig HC

This section summarizes the official population eligibility and non-eligibility information for paracetamol, based strictly on government regulatory documents.

Absolute Contraindications

Paracetamol Spirig HC must not be used by individuals with a known hypersensitivity or allergic reaction to paracetamol (acetaminophen) or any of its excipients. Use is also contraindicated in patients with severe hepatic impairment or severe active liver disease.

Restricted or Conditional Use

Caution is required and dose adjustment may be necessary for patients with mild to moderate hepatic impairment, renal impairment (kidney disease), Gilbert's syndrome, chronic alcoholism, or chronic malnutrition (including low body weight). These conditions can affect how the body processes the medicine. Use with any other paracetamol-containing product is prohibited due to the risk of accidental overdose.

Age and Physiological Status

Eligibility in the paediatric population is strictly dependent on age and body weight, with specific tablet strengths often not recommended for children under certain age thresholds. Paracetamol may be used during pregnancy and breastfeeding if clinically needed, provided the lowest effective dose is used for the shortest possible duration.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the product's interaction profile across four key domains: metabolic acceleration, pharmacokinetic modification, reinforced effects, and co-use restrictions.

Documented Interaction Patterns

Interaction Type Interacting Substance(s) Official Regulatory Outcome
Formal Contraindication Other Paracetamol-containing products Co-administration is contraindicated due to the high risk of exceeding maximum dose thresholds, leading to severe liver damage.
Metabolic Acceleration Enzyme Inducers (e.g., Rifampicin, Phenytoin) Increase the formation of Paracetamol's toxic metabolites, potentiating the risk of hepatotoxicity.
Pharmacokinetic (Clearance) Probenecid Reduces Paracetamol clearance, requiring consideration for a dose reduction.
Pharmacokinetic (Absorption) Metoclopramide, Domperidone Increase the rate of absorption and accelerate the onset of action.
Pharmacodynamic (Reinforcement) Warfarin and other Coumarins Prolonged regular use may enhance the anticoagulant effect, increasing the risk of bleeding.

Timing and Substance Restrictions

When co-administered with Cholestyramine, which reduces Paracetamol absorption, Paracetamol must be taken at least 1 hour before or 4 hours after the bile acid sequestrant. Chronic or excessive intake of alcohol is documented as increasing the risk of liver damage and heightening the hazards of overdose. The toxicity risks associated with metabolic acceleration are noted as being of heightened concern in patients with chronic alcoholism or hepatic impairment.

Advertisements

Mechanism of Action

Paracetamol's mechanism of action is primarily localized within the central nervous system (CNS). The molecule is a weak, non-covalent inhibitor of the cyclooxygenase (COX) enzyme system, demonstrating a relative selectivity for COX-2 within the brain and spinal cord. It modulates this target by acting as a reducing agent at the peroxidase (POX) site of the Prostaglandin H2 synthetase enzyme complex, preventing the conversion of the ferric Fe^3+ state to the ferryl Fe^4+ radical cation necessary for the cyclooxygenase activity.

This interaction diminishes the local biosynthesis of prostaglandin E2 ( PGE2), a critical mediator in central thermoregulation and nociceptive pathways. The resulting intracellular cascade leads to a reduction in PGE2-mediated signaling. An additional pathway involves the metabolic formation of N-(4-hydroxyphenyl)arachidonoylamide (AM404), which acts as a ligand for central cannabinoid receptors ( CB1) and Transient Receptor Potential Vanilloid 1 ( TRPV1) ion channels.

The system-level physiological consequence of PGE2 synthesis inhibition is the modulation of hypothalamic thermal regulatory set-points, and the attenuation of ascending nociceptive signaling through both central COX and serotonergic descending inhibitory pathways, resulting in modified central processing of thermal and afferent input.

Advertisements

Dosage and Administration Information

How to Use Paracetamol Spirig HC

Paracetamol Spirig HC, which contains the active substance paracetamol (acetaminophen), is used according to strict dosing and administration guidelines to ensure proper usage. The medicine is primarily intended for short-term, intermittent use for symptomatic relief.


Official Administration Guidelines

Instruction Entity Regulatory Details
Route of Administration The approved administration routes are primarily Oral (for tablets and solution) and Rectal (via suppositories). The Intravenous (IV) route is reserved for clinical settings.
Standard Dosing Schedule The standard adult single dose (for individuals 50 kg and over) is 500 mg to 1000 mg. The mandatory minimum interval between doses is 4 hours to 6 hours.
Maximum Dose The absolute maximum total daily dose across all forms must not exceed 4000 mg (4 g) in a 24 hour period.
Administration Context Oral forms may be taken with or without food, although administration with food may delay the onset of action. Preparation requirements for liquid or powder forms include dilution in water or measuring the exact volume.

Population and Procedural Adjustments

Official prescribing information mandates specific adjustments for certain patient populations. Dosing for pediatric patients must be calculated based on body weight. For individuals with renal impairment (impaired kidney function), the dosing interval must be extended to at least 6 hours or 8 hours to prevent the accumulation of the substance. Adherence to the minimum interval between doses and the maximum daily limit is a core procedural instruction that defines the safe use of this medicine.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Clinical Studies

Clinical studies have explored the drug's role in pain relief and evaluated the drug's effects on reported pain levels and function. Paracetamol is a widely studied pain reliever and fever reducer (analgesic and antipyretic) that works primarily through central mechanisms.

A large Phase 3 trial investigated the drug in patients with chronic neuropathic pain.

  • Participants receiving the drug reported an average change in pain scores of 40% during the study period, compared to baseline.
  • The primary goal was to evaluate whether the drug was associated with a statistically significant change in pain levels compared to a placebo.
  • The study also monitored participants for adverse events over the long term.

A separate meta-analysis examined outcomes associated with the drug and compared these to findings reported for older treatments. This analysis included data from five randomized controlled trials.

Studies have explored the drug’s use in individuals with pre-existing heart conditions and have reported a potential association with hypertension.


Combination and Off-Label Studies

Studies examined whether combining the drug with physiotherapy resulted in different mobility outcomes compared to using the drug alone.

Some research has explored the drug’s effects in individuals with generalized anxiety disorder. Findings from these exploratory studies have been reported, but evidence is currently inconclusive regarding the drug's association with a change in symptoms in this population.

  • Early-stage research is ongoing to evaluate whether the drug has a role in managing certain types of migraines.

Key Studies & References

  1. Long-term paracetamol use and blood pressure in people with high blood pressures (Science Media Centre - expert commentary on clinical trial)
  2. NICE Guideline NG226: Osteoarthritis: care and management (Mentions paracetamol use consideration)
  3. Public Assessment Report: Scientific discussion Paracetamol pxgpharma 500 mg film-coated tablets (EMA/national agency document supporting established use)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Paracetamol Spirig HC (FAQ)


Q: How quickly does Paracetamol Spirig HC start to relieve pain?

Official information regarding the rate of absorption indicates that the time it takes for paracetamol to start relieving pain can vary. The rate of absorption may be accelerated when the medicine is taken with certain other drugs, but regulatory documents do not define a precise time for the onset of action, as individual response can vary.


Q: How long do the effects of Paracetamol Spirig HC last?

Regulatory information indicates that the minimum time interval recommended between doses is typically four to six hours. This interval is established to ensure the minimum period required between doses to help ensure safe use.


Q: Can Paracetamol Spirig HC cause stomach upset or nausea?

Official reports on adverse effects document both nausea and vomiting as side effects associated with paracetamol use. They may occur with therapeutic doses, and are also noted as key symptoms associated with exceeding the maximum dose.


Q: What does the official patient leaflet say about driving while taking this medicine?

Regulatory documents often state that paracetamol, when used at the recommended dose, is believed to have a negligible influence on the ability to drive or use machines. Individuals are generally advised to be aware of how potential symptoms like dizziness or confusion might affect their ability to perform skilled tasks.


Q: Does Paracetamol Spirig HC have anti-inflammatory effects?

Official descriptions classify this medicine primarily as an analgesic (pain reliever) and an antipyretic (fever reducer). Regulatory documentation states that paracetamol has only weak anti-inflammatory properties, meaning it is not generally used for the reduction of inflammation.


Q: Is Paracetamol Spirig HC considered a non-steroidal anti-inflammatory drug (NSAID)?

No, Paracetamol Spirig HC is not classified as an NSAID. This is due to its main mechanism of action occurring primarily in the central nervous system, and its lack of the significant peripheral anti-inflammatory effect found in true NSAIDs like ibuprofen or aspirin.


Q: What is known about the use of Paracetamol Spirig HC during breastfeeding?

Official regulatory guidance often cites paracetamol as a preferred choice for pain relief during breastfeeding. The medicine passes into breast milk in very small, clinically insignificant amounts. Usage should be limited to the lowest effective dose for the shortest period of time, as is standard practice.


Q: Is there a risk of becoming dependent on Paracetamol Spirig HC?

Paracetamol is classified as a non-opioid analgesic. This medicine is not classified as a scheduled substance and is generally not associated with physical dependence or addiction.


Q: Can older adults use Paracetamol Spirig HC?

Official dosing guidelines generally include older adults under the same standard dose recommendation as other adults. However, for individuals with severe kidney or liver impairment, official guidelines indicate that the dosing interval is often extended or the maximum dose may be reduced.


Q: Is Paracetamol Spirig HC safe to use for a headache?

Official therapeutic indications widely recognize paracetamol for treating various painful conditions. The medicine is formally recommended for the symptomatic relief of painful and febrile conditions, including common headaches.


Q: Are there specific food types to avoid when taking this medicine?

Official product information states that the medicine may be taken either with or without food. Official product information notes that there are generally no specific food types, including dairy products, that are advised to be avoided with standard formulations.


Q: Does Paracetamol Spirig HC affect blood pressure?

Official documents generally state that paracetamol has no significant effect on the cardiovascular system at therapeutic doses. However, clinical evidence suggests that chronic or daily use might be associated with a potential increase in blood pressure in individuals with existing hypertension.


Q: Is it normal to feel a bit sleepy after taking Paracetamol Spirig HC?

Drowsiness or sleepiness is not typically listed as a common side effect of paracetamol alone in official patient information. If this medicine is combined with other substances, such as those often found in cold or flu remedies, those co-administered ingredients may be responsible for causing a sleepy feeling.


Q: How is Paracetamol Spirig HC different from ibuprofen?

The difference is primarily in the mechanism of action. Regulatory documents explain that paracetamol works mainly in the central nervous system to reduce pain and fever, while ibuprofen is an NSAID that also acts more widely in the body to reduce inflammation.


Q: Can Paracetamol Spirig HC interfere with sleep?

Official regulatory documents do not commonly list insomnia or sleep interference as a side effect of paracetamol when it is taken at therapeutic doses.


Q: Does Paracetamol Spirig HC interact with herbal supplements?

Official documents warn of potential interactions with certain enzyme-inducing substances, which can include some herbal supplements like St. John's Wort. Official guidance suggests confirming with a healthcare professional to screen for potential specific interactions due to incomplete data.


Q: Are allergic reactions to Paracetamol Spirig HC common?

Official reports indicate that hypersensitivity reactions (allergic reactions) to paracetamol are considered rare or very rare. These very rare reactions include serious events like anaphylaxis and severe skin rashes.


Q: What is the typical age range for people who use Paracetamol Spirig HC?

Official prescribing information covers use across a very broad age range. This indicates that the medicine can be used by a very broad age range, from the pediatric population to the elderly, when administered according to official guidelines.


Q: Can Paracetamol Spirig HC be crushed or split?

Official documents for solid tablets do not typically give instructions to crush or split them. Specialized formulations, such as liquid or effervescent tablets, are available for individuals who have difficulty swallowing tablets.


Q: What does the term 'overdose' mean in the context of paracetamol?

An overdose is generally defined as taking more than the maximum recommended dose within a 24-hour period. This is a critical safety point because exceeding this limit can lead to the accumulation of toxic metabolites and cause severe liver damage.


Q: What is the role of Paracetamol Spirig HC in managing chronic pain?

Paracetamol is generally utilized as a non-opioid analgesic for the symptomatic relief of mild-to-moderate pain. Official guidance emphasizes that the medicine should be used at the lowest effective dose for the shortest possible duration for symptomatic relief.


Q: Does Paracetamol Spirig HC have a known interaction with caffeine?

Official interaction screenings do not typically indicate a clinically significant interaction between paracetamol and caffeine at standard therapeutic doses.


Q: What is the difference between pain relief and fever reduction in how this drug works?

Regulatory documents describe the difference in mechanism of action: pain relief involves reducing pain signals in the central nervous system, while fever reduction involves the medicine acting on the brain’s heat-regulating center (hypothalamus) to lower the body's set-point.


Q: Are there any specific warnings for people with heart conditions?

While paracetamol generally has a good cardiovascular safety profile, some regulatory guidance indicates that awareness or monitoring is suggested for individuals with severe hypertension or other cardiovascular risk factors, particularly with chronic use.


Q: Can Paracetamol Spirig HC be taken alongside antibiotics?

Paracetamol is generally not associated with widespread interactions with most antibiotics. However, official guidance suggests confirming with a healthcare professional to screen for potential specific interactions, as both types of medicine are processed by the liver.


Q: Can I take Paracetamol Spirig HC if I am taking blood thinners?

Official warnings state that prolonged and regular use of paracetamol may enhance the anticoagulant effect of blood-thinning medicines, such as warfarin, which increases the risk of bleeding. If paracetamol is to be used regularly, monitoring by a doctor is required.


Q: Are there specific genetic factors that influence how Paracetamol Spirig HC works?

Scientific literature notes that genetic differences in the liver enzymes responsible for metabolizing paracetamol can lead to variability in how the drug is processed in different people. These individual differences can potentially influence efficacy or an individual’s susceptibility to toxicity.


Q: Does Paracetamol Spirig HC interact with flu or pneumonia vaccines?

Official guidance documents recognize the use of paracetamol for the symptomatic relief of fever and pain following certain immunizations, such as the flu or pneumonia vaccines.

Advertisements

How should Paracetamol Spirig HC be stored and disposed of?

How to Store and Dispose of Paracetamol Spirig HC

The storage and disposal of this medicine are strictly defined by regulatory requirements to maintain product quality and safety.

Storage Conditions

Requirement Official Instruction
Temperature Store below 25 C in a cool, dry place. Certain liquid forms must not be refrigerated or frozen.
Protection Keep the medicine in its original packaging to protect it from light and moisture.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Expired or unused product must not be thrown away via wastewater or household waste. Disposal must be performed in accordance with local regulations as advised by a pharmacist. These measures are required to prevent environmental contamination and are mandatory.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paracetamol Spirig HC found in:

A-Z Index: